Rezidivierte oder refraktäre KeimzelltumorenWelche Rolle spielt die Hochdosischemotherapie mit autologer Stammzelltransplantation?Relapsed or refractory germ cell tumorsWhat role does high-dose chemotherapy with autologous stem cell transplantation play?

被引：0
|
作者：
L.A. Berger
K. Oechsle
机构：
[1] Universitätsklinikum Hamburg Eppendorf,Hämatologie/Onkologie
来源：
Der Onkologe | 2012年 / 18卷 / 11期
关键词：
D O I：
10.1007/s00761-012-2311-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1031 / 1034
页数：3
相关论文
共 50 条
  • [41] High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study
    Chihara, Dai
    Izutsu, Koji
    Kondo, Eisei
    Sakai, Rika
    Mizuta, Shuichi
    Yokoyama, Kenji
    Kaneko, Hiroto
    Kato, Koji
    Hasegawa, Yuichi
    Choul, Takaaki
    Sugaharall, Hiroyuki
    Henzan, Hideho
    Sakamaki, Hisashi
    Suzuki, Ritsuro
    Suzumiya, Junji
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (05) : 684 - 689
  • [42] Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
    Duarte, Bruno K. L.
    Valente, Isabella
    Vigorito, Afonso C.
    Aranha, Francisco J. P.
    Oliveira-Duarte, Gislaine
    Miranda, Eliana C. M.
    Lorand-Metze, Irene
    Pagnano, Katia B.
    Delamain, Marcia
    Marques Junior, Jose F.
    Brandalise, Silvia R.
    Nucci, Marcio
    De Souza, Carmino A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : 449 - 454
  • [43] Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation
    Abdallah, Al-Ola
    Dunavin, Neil
    McClune, Brian
    Shune, Leyla
    Dias, Ajoy L.
    Mahmoudjafari, Zahra
    Hochard, Erica
    McGuirk, Joseph P.
    Ganguly, Siddhartha
    BLOOD, 2018, 132
  • [44] Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
    Illhardt, T.
    Ebinger, M.
    Schwarze, C. P.
    Feuchtinger, T.
    Furtwaengler, R.
    Schlegel, P. G.
    Klingebiel, T.
    Greil, J.
    Beck, J. F.
    Handgretinger, R.
    Lang, P.
    KLINISCHE PADIATRIE, 2014, 226 (6-7): : 351 - 356
  • [45] Outcomes of Daratumumab, Pomalidomide, and Dexamethasone, Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation, in Patients With Relapsed/Refractory Multiple Myeloma
    Abdallah, Al-Ola
    Mohyuddin, Ghulam Rehman
    Mahmoudjafari, Zahra
    Atrash, Shebli
    Kawsar, Hameem
    Sigle, Monia
    Shune, Leyla
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E212 - E219
  • [46] High-dose chemotherapy and autologous hematopoietic stem-cell rescue for treatment of relapsed and refractory Wilms tumor: Re-evaluating outcomes
    Rossoff, Jenna
    Tse, William T.
    Duerst, Reggie E.
    Schneiderman, Jennifer
    Morgan, Elaine
    Kletzel, Morris
    Chaudhury, Sonali
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 35 (5-6) : 316 - 321
  • [47] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN REFRACTORY/METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS: GATA SINGLE CENTER RESULTS
    Karadurmus, N.
    Ataergin, A. S.
    Erdem, G.
    Cakar, M.
    Barista, I.
    Turker, T.
    Ozaydin, S.
    Ozturk, M.
    Arpaci, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 286 - 286
  • [48] High-dose chemotherapy and autologous stem cell transplantation in refractory/metastatic nonseminomatous germ cell-tumors: A retrospective study of the Turkish Oncology Association.
    Ozturk, Mustafa
    Arpaci, Fikret
    Ozaydin, Sukru
    Karadurmus, Nuri
    Ozdemir, Evren
    Ataergin, Selmin
    Erdem, Gokhan
    Karaca, Halit
    Cakar, Mustafa
    Turker, Turker
    Ozet, Ahmet
    Kuzhan, Okan
    Kilic, Selim
    Komurcu, Seref
    Ozet, Gulsum
    Dagdas, Simten
    Ozturk, Bekir
    Sivgin, Serdar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens
    Mariotti, Jacopo
    Ricci, Francesca
    Giordano, Laura
    Taurino, Daniela
    Sarina, Barbara
    De Philippis, Chiara
    Mannina, Daniele
    Carlo-Stella, Carmelo
    Bramanti, Stefania
    Santoro, Armando
    CELLS, 2024, 13 (02)
  • [50] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory lymphomas. Sixteen years experience of a single center
    Koumakis, G.
    Tsoukalas, N.
    Tryfonopoulos, D.
    Demiri, S.
    Vassilomanolakis, M.
    Barbounis, V.
    Droufakou, S.
    Filis, I.
    Moraki, M.
    Efremidis, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 353 - 353
12345